Literature DB >> 7399686

Production of Clostridium difficile antitoxin.

M Ehrich, R L Van Tassell, J M Libby, T D Wilkins.   

Abstract

We have produced antitoxin to the toxin of Clostridium difficile in rabbits and in goats. Antitoxin dilutions of 1/8,000 and 1/5,120 were capable of neutralizing lethal doses of the toxin in mice and in tissue culture, respectively.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7399686      PMCID: PMC551056          DOI: 10.1128/iai.28.3.1041-1043.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  Comparison of five regimens for treatment of experimental clindamycin-associated colitis.

Authors:  J G Bartlett; T W Chang; A B Onderdonk
Journal:  J Infect Dis       Date:  1978-07       Impact factor: 5.226

2.  Identification of Clostridium difficile as a cause of pseudomembranous colitis.

Authors:  R H George; J M Symonds; F Dimock; J D Brown; Y Arabi; N Shinagawa; M R Keighley; J Alexander-Williams; D W Burdon
Journal:  Br Med J       Date:  1978-03-18

3.  Colitis induced by Clostridium difficile.

Authors:  J G Bartlett; T Chang; N S Taylor; A B Onderdonk
Journal:  Rev Infect Dis       Date:  1979 Mar-Apr

4.  Neutralization of Clostridium difficile toxin by Clostridium sordellii antitoxins.

Authors:  T W Chang; S L Gorbach; J B Bartlett
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

5.  Prevention of clindamycin-induced colitis in hamsters by Clostridium sordellii antitoxin.

Authors:  M Allo; J Silva; R Fekety; G D Rifkin; H Waskin
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

6.  Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients.

Authors:  T W Chang; J G Bartlett; S L Gorbach; A B Onderdonk
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

7.  Aetiology of antimicrobial-agent-associated colitis.

Authors:  W L George; V L Sutter; E J Goldstein; S L Ludwig; S M Finegold
Journal:  Lancet       Date:  1978-04-15       Impact factor: 79.321

8.  Pseudomembranous colitis: Presence of clostridial toxin.

Authors:  H E Larson; A B Price
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

9.  Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin.

Authors:  G D Rifkin; F R Fekety; J Silva
Journal:  Lancet       Date:  1977-11-26       Impact factor: 79.321

  9 in total
  44 in total

1.  Toxin A of Clostridium difficile is a potent cytotoxin.

Authors:  K D Tucker; P E Carrig; T D Wilkins
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

2.  Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate.

Authors:  D M Lyerly; E F Bostwick; S B Binion; T D Wilkins
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

3.  Antigenic cross-reactivity and functional inhibition by antibodies to Clostridium difficile toxin A, Streptococcus mutans glucan-binding protein, and a synthetic peptide.

Authors:  B W Wren; R R Russell; S Tabaqchali
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

4.  Molecular characterization of the Clostridium difficile toxin A gene.

Authors:  C H Dove; S Z Wang; S B Price; C J Phelps; D M Lyerly; T D Wilkins; J L Johnson
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

5.  Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters.

Authors:  J F Torres; D M Lyerly; J E Hill; T P Monath
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

6.  Presence of Clostridium difficile toxin in guinea pigs with penicillin-associated colitis.

Authors:  S W Rothman
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

7.  Purified Clostridium difficile cytotoxin stimulates guanylate cyclase activity and inhibits adenylate cyclase activity.

Authors:  D L Vesely; K D Straub; C M Nolan; R D Rolfe; S M Finegold; T P Monson
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

8.  Purification and characterization of an enterotoxin from Bacteroides fragilis.

Authors:  R L Van Tassell; D M Lyerly; T D Wilkins
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

9.  Criteria for detection of Clostridium difficile toxin production by counterimmunoelectrophoresis.

Authors:  R P Rennie; J M Elliott; M A Nardini; J H Thornley
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

10.  Problems associated with counterimmunoelectrophoresis assays for detecting Clostridium difficile toxin.

Authors:  S E West; T D Wilkins
Journal:  J Clin Microbiol       Date:  1982-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.